Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
---|---|
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00139503 |
To conduct several studies on genes and the fibrinolytic capacity of human endothelium.
Condition | Intervention |
---|---|
Cardiovascular Diseases Heart Diseases Thrombosis Blood Disease Coronary Disease |
Drug: angiotensin converting enzyme inhibitor |
Study Type: | Interventional |
Study Design: | Prevention |
Study Start Date: | August 2000 |
Study Completion Date: | July 2008 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
No eligibility criteria
Study ID Numbers: | 245 |
Study First Received: | August 29, 2005 |
Last Updated: | July 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00139503 |
Health Authority: | United States: Federal Government |
Arterial Occlusive Diseases Coronary Disease Embolism and Thrombosis Heart Diseases Embolism Hematologic Diseases |
Myocardial Ischemia Vascular Diseases Arteriosclerosis Ischemia Thrombosis Coronary Artery Disease |
Cardiovascular Diseases |